Renaissance Technologies’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,102
| Closed | -$56K | – | 4105 |
|
|
2024
Q1 | $56K | Sell |
11,102
-372
| -3% | -$2.31K | ﹤0.01% | 3469 |
|
|
2023
Q4 | $77K | Buy |
+11,474
| New | +$101K | ﹤0.01% | 3369 |
|
|
2023
Q3 | – | Sell |
-2,390
| Closed | -$50K | – | 4236 |
|
|
2023
Q2 | $50K | Sell |
2,390
-13,199
| -85% | -$407K | ﹤0.01% | 3618 |
|
|
2023
Q1 | $419K | Buy |
15,589
+5,346
| +52% | +$249K | ﹤0.01% | 2971 |
|
|
2022
Q4 | $363K | Buy |
+10,243
| New | +$1.23M | ﹤0.01% | 3133 |
|
|
2021
Q4 | – | Sell |
-4,429
| Closed | -$888K | – | 4309 |
|
|
2021
Q3 | $888K | Buy |
4,429
+3,308
| +295% | +$786K | ﹤0.01% | 2613 |
|
|
2021
Q2 | $286K | Sell |
1,121
-2,442
| -69% | -$609K | ﹤0.01% | 3161 |
|
|
2021
Q1 | $946K | Buy |
+3,563
| New | +$1.12M | ﹤0.01% | 2634 |
|
|
2020
Q2 | – | Sell |
-9,039
| Closed | -$1.84M | – | 3840 |
|
|
2020
Q1 | $1.84M | Buy |
9,039
+4,268
| +89% | +$1.36M | ﹤0.01% | 2092 |
|
|
2019
Q4 | $2.13M | Sell |
4,771
-1,940
| -29% | -$689K | ﹤0.01% | 2295 |
|
|
2019
Q3 | $2.06M | Sell |
6,711
-3,243
| -33% | -$1.05M | ﹤0.01% | 2266 |
|
|
2019
Q2 | $3.17M | Buy |
9,954
+656
| +7% | +$227K | ﹤0.01% | 2093 |
|
|
2019
Q1 | $3.9M | Buy |
9,298
+860
| +10% | +$345K | ﹤0.01% | 1965 |
|
|
2018
Q4 | $2.57M | Sell |
8,438
-856
| -9% | -$277K | ﹤0.01% | 2092 |
|
|
2018
Q3 | $3.35M | Buy |
9,294
+1,620
| +21% | +$554K | ﹤0.01% | 2030 |
|
|
2018
Q2 | $2.81M | Buy |
7,674
+2,206
| +40% | +$786K | ﹤0.01% | 2099 |
|
|
2018
Q1 | $1.62M | Buy |
5,468
+2,234
| +69% | +$660K | ﹤0.01% | 2445 |
|
|
2017
Q4 | $1.35M | Buy |
3,234
+600
| +23% | +$214K | ﹤0.01% | 2539 |
|
|
2017
Q3 | $869K | Buy |
2,634
+1,853
| +237% | +$505K | ﹤0.01% | 2619 |
|
|
2017
Q2 | $185K | Buy |
+781
| New | +$177K | ﹤0.01% | 3007 |
|
|
2015
Q2 | – | Sell |
-663
| Closed | -$5.65M | – | 3427 |
|
|
2015
Q1 | $5.65M | Buy |
663
+615
| +1,281% | +$5.38M | 0.01% | 1282 |
|
|
2014
Q4 | $422K | Buy |
+48
| New | +$279K | ﹤0.01% | 2484 |
|
Other funds holding EIGR
Renaissance Technologies's EIGR Position: Q2 2024 in Review
Renaissance Technologies sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2024, closing a stake of 11,102 shares — an estimated $56K sold.
Renaissance Technologies first reported a position in EIGR in Q4 2014 and held it in 22 quarters. The position peaked at $5.65M in Q1 2015. 2 funds tracked by Wall St. Rank hold EIGR as of Q2 2024.
- Renaissance Technologies reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
- Renaissance Technologies sold 11,102 Eiger BioPharmaceuticals, Inc. shares in Q2 2024, an estimated $56K.
- Renaissance Technologies first reported a position in Eiger BioPharmaceuticals, Inc. in Q4 2014 and held it in 22 quarters.
- Renaissance Technologies's Eiger BioPharmaceuticals, Inc. position peaked at $5.65M in Q1 2015.
- 2 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2024.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.